 |
 |
|
|
|  PubMed
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 February 1994 | Volume 120 Issue 3 | Pages 218-226
Objective: To identify complications amenable to prevention in adults with glycogen storage disease (GSD) types Ia, Ib, and III and to determine the effect of the disease on social factors.
Design: Case series and clinical review.
Setting: Referral medical centers in the United States and Canada.
Patients: All patients with GSD-Ia (37 patients), GSD-Ib (5 patients), and GSD-III (9 patients) who were 18 years of age or older.
Measurements: Ultrasound or radiographic studies identified liver adenomas, nephrocalcinosis, or kidney stones. Radiographic studies identified osteopenia. Reports of the clinical examination, serum chemistry results, and social data were obtained.
Results: For patients with GSD-Ia, problems included short stature (90%), hepatomegaly (100%), hepatic adenomas (75%), anemia (81%), proteinuria or microalbuminuria (67%), kidney calcifications (65%), osteopenia or fractures or both (27%), increased alkaline phosphatase (61%) and
Conclusions: For GSD-Ia, hyperuricemia and pyelonephritis should be treated to prevent nephrocalcinosis and additional renal damage. For GSD-Ib, granulocyte-colony-stimulating factor may prevent bacterial infections. For GSD-III, more data are required to determine whether the myopathy and cardiomyopathy can be prevented. Most of the patients with GSD-I and GSD-III had 12 or more years of education and were either currently in school or employed.
Author and Article Information
From the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Washington University School of Medicine, St. Louis, Missouri; the University of California, Davis, Sacramento, California; Duke University Medical Center, Durham, North Carolina; The Children's Hospital, Harvard Medical School, Boston, Massachusetts; University of Alberta, Edmonton, Alberta, Canada; University of Manitoba, Winnipeg, Manitoba, Canada; Institute for Molecular Genetics, Houston, Texas; McMaster University, Hamilton, Ontario, Canada; St. Louis Children's Hospital, St. Louis, Missouri; Palo Alto Medical Foundation, Palo Alto, California; Children's Hospital of Los Angeles, Los Angeles, California; Tufts-New England Medical Center Hospitals, Boston, Massachusetts.
REVIEW
Glycogen Storage Disease in Adults
-glutamyltransferase (93%) activities, and increased serum cholesterol (76%) and triglyceride (100%) levels. Hyperuricemia was frequent (89%). Patients with GSD-Ib had severe recurrent bacterial infections and gingivitis. In patients with GSD-III, 67% (6 of 9) had increased creatinine kinase activity. Four of these patients had myopathy and cardiomyopathy.
Requests for Reprints: Rosalind A. Coleman, MD, Department of Nutrition, University of North Carolina at Chapel Hill, School of Public Health, CB# 7400, Chapel Hill, NC 27599-7400.
Grant Support: In part by NIH grants RR02172 and M01-RR30 National Center for Research Sources, General Clinical Research Centers program, and the Duke GSD fund.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  E. Storch, M. Keeley, L. Merlo, M. Jacob, C. Correia, and D. Weinstein Psychosocial Functioning in Youth with Glycogen Storage Disease Type I J. Pediatr. Psychol., August 1, 2008; 33(7): 728 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, J. K. Oeser, C. Yang, S. Sarkar, S. I. Hackl, A. H. Hasty, O. P. McGuinness, W. Paradee, J. C. Hutton, D. R. Powell, et al. Deletion of the Gene Encoding the Ubiquitously Expressed Glucose-6-phosphatase Catalytic Subunit-related Protein (UGRP)/Glucose-6-phosphatase Catalytic Subunit-beta Results in Lowered Plasma Cholesterol and Elevated Glucagon J. Biol. Chem., December 29, 2006; 281(52): 39982 - 39989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. W. Moe and O. Bonny Genetic Hypercalciuria J. Am. Soc. Nephrol., March 1, 2005; 16(3): 729 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Hanbidge, P. M. Buckler, M. E. O'Malley, and S. R. Wilson From the RSNA Refresher Courses: Imaging Evaluation for Acute Pain in the Right Upper Quadrant RadioGraphics, July 1, 2004; 24(4): 1117 - 1135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Weinstein, C. N. Roy, M. D. Fleming, M. F. Loda, J. I. Wolfsdorf, and N. C. Andrews Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease Blood, November 15, 2002; 100(10): 3776 - 3781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Grazioli, M. P. Federle, G. Brancatelli, T. Ichikawa, L. Olivetti, and A. Blachar Hepatic Adenomas: Imaging and Pathologic Findings RadioGraphics, July 1, 2001; 21(4): 877 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Calderwood, L. Kilpatrick, S. D. Douglas, M. Freedman, K. Smith-Whitley, M. Rolland, and J. Kurtzberg Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b Blood, January 15, 2001; 97(2): 376 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kiechl, U. Kohlendorfer, C. Thaler, D. Skladal, M. Jaksch, B. Obermaier-Kusser, and J. Willeit Different clinical aspects of debrancher deficiency myopathy J. Neurol. Neurosurg. Psychiatry, September 1, 1999; 67(3): 364 - 368. [Abstract] [Full Text]
|
|
|
|
 |
|
 F.J. Service Hypoglycemic Disorders N. Engl. J. Med., April 27, 1995; 332(17): 1144 - 1152. [Full Text] [PDF]
|
|
